Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001477932-25-002896
Filing Date
2025-04-22
Accepted
2025-04-22 17:14:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT vnrx_424b5.htm 424B5 332433
2 vnrx_424b5img2.jpg GRAPHIC 4091
3 vnrx_424b5img3.jpg GRAPHIC 4324
4 vnrx_424b5img5.jpg GRAPHIC 3168
5 vnrx_424b5img6.jpg GRAPHIC 2581
6 vnrx_s3img4.jpg GRAPHIC 5091
  Complete submission text file 0001477932-25-002896.txt   360741
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283088 | Film No.: 25858549
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)